Waldencast plc (NASDAQ:WALD) Shares Sold by State Street Corp

State Street Corp lowered its position in shares of Waldencast plc (NASDAQ:WALD) by 1.1% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 456,500 shares of the company’s stock after selling 5,046 shares during the quarter. State Street Corp’s holdings in Waldencast were worth $1,662,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in WALD. Renaissance Technologies LLC acquired a new stake in shares of Waldencast during the second quarter worth about $239,000. Milestones Administradora de Recursos Ltda. raised its position in Waldencast by 10.0% during the 3rd quarter. Milestones Administradora de Recursos Ltda. now owns 2,200,000 shares of the company’s stock worth $8,008,000 after buying an additional 200,000 shares during the last quarter. Bleakley Financial Group LLC raised its position in Waldencast by 75.2% during the 3rd quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock worth $96,000 after buying an additional 11,288 shares during the last quarter. McAdam LLC acquired a new stake in Waldencast during the 3rd quarter valued at approximately $62,000. Finally, Catalina Capital Group LLC purchased a new stake in shares of Waldencast in the 3rd quarter valued at $58,000. Hedge funds and other institutional investors own 41.97% of the company’s stock.

Wall Street Analysts Forecast Growth

WALD has been the subject of several recent research reports. Telsey Advisory Group reissued an “outperform” rating and set a $6.00 target price on shares of Waldencast in a report on Monday, November 18th. DA Davidson boosted their price objective on Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a report on Wednesday, December 4th. Canaccord Genuity Group raised their target price on Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a report on Friday, November 22nd. TD Cowen assumed coverage on Waldencast in a research report on Monday, December 16th. They set a “hold” rating and a $4.30 price target for the company. Finally, Canaccord Genuity Group began coverage on Waldencast in a research report on Friday, October 25th. They issued a “buy” rating and a $5.00 price objective on the stock. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $5.76.

Waldencast Stock Up 3.3 %

NASDAQ:WALD opened at $4.02 on Thursday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47. Waldencast plc has a 52 week low of $2.40 and a 52 week high of $11.50. The stock’s 50-day moving average price is $3.54 and its 200-day moving average price is $3.48.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.